| Adalimumab response best yet in juvenile rheumatoid arthritis.(Clinical Rounds): An article from: Skin & Allergy News | Digitalby Jeff Evans (Author)
| List Price: | $9.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Thomson Gale | | Page Count: | 2 Pages | | Publication Date: | February 01, 2007 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Skin & Allergy News, published by Thomson Gale on February 1, 2007. The length of the article is 584 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Adalimumab response best yet in juvenile rheumatoid arthritis.(Clinical Rounds)Author: Jeff EvansPublication: Skin & Allergy News (Magazine/Journal)Date: February 1, 2007Publisher: Thomson GaleVolume: 38 Issue: 2 Page: 42(1)Distributed by Thomson Gale |
|
